Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in Cornebarrieu – page 92

1 551 clinical trials in Cornebarrieu, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Cornebarrieu at a glance
1 551
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

1 551 trials in Cornebarrieu

Open in trial search

Gastric cancer

Not recruiting

Study of spartalizumab combined with FLOT chemotherapy (fluorouracil, leucovorin, oxaliplatin, docetaxel) for patients with resectable gastric cancer before and after surgery

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Centre Francois Baclesse

Obesity

Not recruiting

Study of Tirzepatide for Reducing Obesity and Related Health Issues in Adolescents

Investigational
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Tirzepatide
  • Sponsor:Eli Lilly & Co.

Study on the Effects of TAK-341 for Patients with Multiple System Atrophy

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Indenebart
  • Sponsor:Takeda Development Center Americas Inc.

Breast cancer

Not recruiting

Study of Camizestrant and CDK4/6 Inhibitor for Patients with Advanced Breast Cancer with ESR1 Mutation

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:AstraZeneca AB

Prostate cancer

Not recruiting

Study on Hormonal Treatment with Leuprorelin Acetate for Prostate Cancer Patients at High Risk of Recurrence After Surgery

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Leuprorelin Acetate
  • Sponsor:Unicancer

Study on Bezafibrate for Patients with Primary Sclerosing Cholangitis and Persistent Cholestasis Despite Ursodeoxycholic Acid Therapy

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bezafibrate
  • Sponsor:Assistance Publique Hopitaux De Paris

Study of FNP-223 tablets to slow disease progression in patients with Progressive Supranuclear Palsy (PSP)

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Egalognastat hydrochloride
  • Sponsor:Ferrer Internacional S.A.

Bartonellosis

Not recruiting

Study on Gentamicin and Azithromycin for Treating Lymph Node Infection in Cat Scratch Disease Patients

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Azithromycin
  • Sponsor:Centre Hospitalier Universitaire De Toulouse

Study on Dexamethasone for Patients with Herpes Simplex Virus Encephalitis

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Centre Hospitalier Universitaire Grenoble Alpes

Hypochondroplasia

Not recruiting

Study on the Effectiveness and Safety of Vosoritide for Children with Hypochondroplasia

Registered drug
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Vosoritide
  • Sponsor:Biomarin Pharmaceutical Inc.

Acute myeloid leukaemia+2

Not recruiting

Study on Continued Treatment with Sabatolimab for Adults with High-Risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Unfit for Chemotherapy

Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Novartis Pharma AG

Takayasu's arteritis

Not recruiting

Study on Infliximab and Tocilizumab for Patients with Refractory or Relapsing Takayasu Arteritis

Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Infliximab
  • Sponsor:Assistance Publique Hopitaux De Paris

Other cities in France

The busiest research cities in the country

All 376 cities in France

Clinical research in Cornebarrieu

What the registry says about research in the country

01 Lung Cancer Research

Studies focusing on innovative treatments for non-small cell lung cancer, particularly evaluating immunotherapy combinations and targeted therapies for elderly patients.

  • Immunotherapy optimization
  • Elderly patient care protocols
  • Treatment effectiveness evaluation

Notable research includes novel approaches combining atezolizumab with traditional chemotherapy protocols.

02 Breast Cancer Studies

Comprehensive research on hormone-sensitive breast cancer, investigating optimized treatment durations and comparing therapeutic approaches for metastatic cases.

  • Hormone therapy optimization
  • Metastatic treatment strategies
  • Personalized therapy approaches

Research focuses on improving outcomes for patients with ER+ HER2- breast cancer variants.

03 Gastrointestinal Oncology

Advanced studies in colon carcinoma and biliary tract cancers, exploring both surgical and chemotherapy innovations.

  • Adjuvant treatment protocols
  • Neoadjuvant therapy assessment
  • Elderly patient care strategies

Including groundbreaking research on circulating tumor DNA for treatment decision-making.

04 Neurological Conditions

Innovative research in migraine management, exploring emergency interventions using advanced oxygen therapy techniques.

  • Emergency treatment protocols
  • High-flow oxygen therapy
  • Acute pain management

Focusing on rapid relief strategies in emergency department settings.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.